Peer-reviewed veterinary case report
Survival after surgery for oral fibrosarcoma in dogs
By Frazier, S A et al.·Published in Veterinary and comparative oncology·2012·William R. Prichard Veterinary Medical Teaching Hospital, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Outcome in dogs with surgically resected oral fibrosarcoma (1997-2008).
- Species:
- dog
Plain-English summary
A group of 29 dogs with oral fibrosarcoma, a type of tumor in the mouth, underwent surgery to remove the growth. Some dogs received only surgery, while others also had radiation therapy afterward. The results showed that most dogs lived for over two years after treatment, with a good chance of not having the cancer come back for at least a year. However, about a quarter of the dogs did experience a return of the tumor or spread to other areas. Overall, the combination of surgery and radiation therapy helped improve survival times for these dogs.
People also search for: dog oral tumor treatment · fibrosarcoma in dogs prognosis · dog mouth cancer surgery recovery
Abstract
Oral fibrosarcoma (FSA) is a common oral tumour in dogs, and historically reported survival times after surgical excision range from 7.0 to 12.2 months with local recurrence rates of 32-57%. The purpose of this retrospective study was to report outcome in a cohort of dogs with oral FSA treated with surgical excision with or without adjuvant radiation therapy. Twenty-nine dogs with a histological diagnosis of FSA arising from the oral cavity that underwent surgical resection of their oral FSA were included in this study. Twenty-one dogs were treated with surgical excision alone and eight dogs with both surgery and radiation therapy. The median progression-free interval was >653 days. The median survival time was 743 days. The 1- and 2-year survival rates were 87.7 and 57.8%, respectively. Seven (24.1%) dogs developed local recurrence. Seven dogs (24.1%) developed metastasis.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/22236095/